Search Results - "Gullick, N. J."

Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis by Gullick, N. J., Abozaid, H. S., Jayaraj, D. M., Evans, H. G., Scott, D. L., Choy, E. H., Taams, L. S.

“…Summary Prognosis of patients with early inflammatory arthritis (EIA) is highly variable. The aim of this study was to compare, longitudinally and…”
Get full text

Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data by Gullick, Nicola J, Mian, Aneela N, Ibrahim, Fowzia, Walker, David, Hassell, Andrew, Kiely, Patrick D W, Walsh, David A, Young, Adam, Scott, David L

“…The optimal treatment for active rheumatoid arthritis (RA) is unresolved, particularly in early RA. We used data from an observational cohort to develop the…”
Get full text

Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial by Tjärnlund, Anna, Tang, Quan, Wick, Cecilia, Dastmalchi, Maryam, Mann, Herman, Tomasová Studýnková, Jana, Chura, Radka, Gullick, Nicola J, Salerno, Rosaria, Rönnelid, Johan, Alexanderson, Helene, Lindroos, Eva, Aggarwal, Rohit, Gordon, Patrick, Vencovsky, Jiri, Lundberg, Ingrid E

“…To study the effects of abatacept on disease activity and on muscle biopsy features of adult patients with dermatomyositis (DM) or polymyositis (PM). Twenty…”
Get more information

Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years by GULLICK, Nicola J, OAKLEY, Stephen P, ZAIN, Amir, GIBSON, Terence, JONES, Tim, MISTLIN, Alan, REES, Jonathan D, PANAYI, Gabriel S, KIRKHAM, Bruce W

Get full text

Co-morbidities in established rheumatoid arthritis by Gullick, Nicola J, Scott, David L

“…Abstract Co-morbid conditions are common in patients with rheumatoid arthritis (RA). Although the presence of co-morbid conditions can be assessed using…”
Get full text

Ageing and the Musculoskeletal System I75. Musculoskeletal Ageing: From Epidemiology to Clinical Trials by Cooper, C., Vasilaki, A., McArdle, A., Jackson, M. J., Belluantono, I., Bruce, I., Rahman, A., Muller-Ladner, U., Gullick, N. J., Jordan, K., Steultjens, M., van der Esch, M., Brandon, M., Dures, E., Hewlett, S., Ambler, N., Goodchild, C., Hale, E., Morris, M., Fraser, B., Dasgupta, B., Mallen, C., Mason, J., Mackie, S., Helliwell, P., Van den Berg, W., Bertrand, J., Dell'Accio, F., Vincent, T., Snowden, N., Devakumar, V., Shenker, N., Guest, L., Bosworth, A., Corrigan, P., Ainsworth, P., Lowe, W. A., Adams, J., Protheroe, J., Robinson, S., Adebajo, A., Bowen, C., Siddle, H., Hall, A.

Get full text

Basic science 232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function by Heathfield, S., Parker, B., Zeef, L., Bruce, I., Alexander, Y., Collins, F., Stone, M., Wang, E., Williams, A. S., Wright, H. L., Thomas, H. B., Moots, R. J., Edwards, S. W., Bullock, C., Chapman, V., Walsh, D. A., Mobasheri, A., Kendall, D., Kelly, S., Bayley, R., Buckley, C. D., Young, S. P., Rump-Goodrich, L., Middleton, J., Chen, L., Fisher, R., Kollnberger, S., Shastri, N., Kessler, B. M., Bowness, P., Nazeer Moideen, A., Evans, L., Osgood, L., Jones, S. A., Nowell, M. A., Mahadik, Y., Young, S., Morgan, M., Gordon, C., Harper, L., Giles, J. L., Paul Morgan, B., Harris, C. L., Rysnik, O. J., McHugh, K., Payeli, S., Marroquin, O., Shaw, J., Renner, C., Nayar, S., Cloake, T., Bombardieri, M., Pitzalis, C., Buckley, C., Barone, F., Lane, P., Coles, M., Williams, E. L., Edwards, C. J., Cooper, C., Oreffo, R. O., Dunn, S., Crawford, A., Wilkinson, M., Le Maitre, C., Bunning, R., Daniels, J., Phillips, K. L. E., Chiverton, N., Le Maitre, C. L., Ridley, A., Wong-Baeza, I., Keidel, S., Chan, A., Gullick, N. J., Abozaid, H. S., Jayaraj, D. M., Evans, H. G., Scott, D. L., Choy, E. H., Taams, L. S., Hickling, M., Golor, G., Jullion, A., Shaw, S., Kretsos, K., Bari, S. F., Rhys-Dillon, B., Amos, N., Siebert, S., Bunning, R. D., Haddock, G., Cross, A. K., Kate, I., Phillips, E., Cross, A., Bunning, R. A. D., Ceeraz, S., Spencer, J., Choy, E.

Get full text

Rheumatoid arthritis - clinical aspects: 134. Predictors of Joint Damage in South Africans with Rheumatoid Arthritis by Ickinger, C., Musenge, E., Tikly, M., Barnes, J., Donnison, C., Scott, M., Bartholomew, P., Rynne, M., Hamilton, J., Saravanan, V., Heycock, C., Kelly, C., de la Torre, I., Moura, R. A., Leandro, M., Edwards, J., Cambridge, G., Daniels, L. E., Gullick, N. J., Rees, J. D., Kirkham, B. W., Rees, J., Scott, I. C., Johnson, D., Scott, D. L., Kingsley, G., Ma, M. H., Cope, A. P., Brode, S., Nisar, M. K., Ostor, A. J., Oakley, S. P., Jones, T., Mistlin, A., Panayi, G. S., El Miedany, Y., Palmer, D., Porkodi, R., Rajendran, P., Waller, R., Williamson, L., Collins, D., Price, E., Juarez, M. J., El Gaafary, M., Youssef, s., Cramp, F., Hewlett, S., Almeida, C., Kirwan, J., Choy, E., Chalder, T., Pollock, J., Christensen, R., Mirjafari, H., Verstappen, S., Bunn, D., Edlin, H., Charlton-Menys, V., Pemberton, P., Marshall, T., Wilson, P., Lunt, M., Symmons, D., Bruce, I. N., Bell, C., Rowe, I. F., Jayakumar, K., Norton, S. J., Dixey, J., Williams, P., Young, A., Kurunadalingam, H., Parwaiz, I., Kumar, K., Howlett, K., Hands, B., Raza, K., Pitzalis, C., Buckley, C., Kelly, S., Filer, A., Wheater, G., Hogan, V. E., Onno Teng, Y., Tekstra, J., Tuck, S. P., Lafeber, F. P., Huizinga, T. W., Bijlsma, J. W., Francis, R. M., Datta, H. K., van Laar, J., Pratt, A. G., Charles, P. J., Choudhury, M., Wilson, G., Venables, P. J., Isaacs, J., Stack, R.

Get full text

Cytokines and Inflammatory Mediators [30-39]: 30. The LPS Stimulated Production of Interleukin-10 is not Associated with -819C/T and -592C/A Promoter Polymorphisms in Healthy Indian Subjects by Shukla, S., Lawrence, A., Aggarwal, A., Naik, S., Gullick, N. J., Evans, H. G., Jayaraj, D., Kirkham, B. W., Taams, L. S., Judah, S. M., Nixon, N., Dawes, P., Mattey, D. L., Yeo, L., Schmutz, C., Toellner, K.-M., Salmon, M., Filer, A. D., Buckley, C., Raza, K., Scheel-Toellner, D., Hashizume, M., Yoshida, H., Koike, N., Suzuki, M., Mihara, M., Stavropoulos-Kalinoglou, A., Metsios, G. S., Douglas, K. M., Panoulas, V. F., Koutedakis, Y., Kitas, G. D., Church, L. D., Hildago, E., Howlett, K., Thomas, A., Rapecki, S., Buckley, C. D., Juarez, M., Kolasinski, J., Govindan, J., Quilter, A., Williamson, L., Collins, D. A., Price, E. J., Gasparyan, A. Y., Toms, T. E., Douglas, K., Lachmann, H. J., Kuemmerle-Deschner, J. B., Hachulla, E., Hoyer, J., Smith, J., Leslie, K., Kone-Paut, I., Braun, J., Widmer, A., Patel, N., Preiss, R., Hawkins, P. N.

Get full text

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review by Al-Shakarchi, Israa, Gullick, Nicola J, Scott, David L

“…Rheumatoid arthritis (RA) remains a major clinical problem with many patients having continuing systemic inflammatory disease resulting in progressive erosive…”
Get full text

Abatacept in the Treatment of Adult Dermatomyositis and Polymyositis: a Randomized, Treatment Delayed-Start Trial by Lundberg, IE, Tjarnlund, A, Tang, Q, Wick, C, Dastmalchi, M, Mann, HF, Studynkova, JT, Chura, R, Gullick, NJ, Salerno, R, Lindroos, E, Gordon, P, Vencovsky, J

Get full text